#9626. A Descriptive analysis of urine drug screen results in patients with opioid use disorder managed in a primary care setting

September 2026publication date
Proposal available till 15-05-2025
4 total number of authors per manuscript0 $

The title of the journal is available only for the authors who have already paid for
Journal’s subject area:
Medicine
Places in the authors’ list:
place 1place 2place 3place 4
FreeFreeFreeFree
2350 $1200 $1050 $900 $
Contract №9626.1 Contract №9626.2 Contract №9626.3 Contract №9626.4
1 place - free (for sale)
2 place - free (for sale)
3 place - free (for sale)
4 place - free (for sale)

Abstract:
Background: Urine drug screening (UDS) is commonly used as part of treatment for opioid use disorder (OUD), including treatment with buprenorphine-naloxone for OUD in a primary care setting. Very little is known about the value of UDS, the optimum screening frequency in general, or its specific use for buprenorphine treatment in primary care. To address this question, we thought that in a stable population receiving buprenorphine-naloxone in the primary care setting it would be useful to know how often UDS yielded expected and unexpected results. Methods: We present a descriptive analysis of UDS results in patients treated with buprenorphine-naloxone for OUD in a primary care setting over a two-year period. An unexpected test result is:1.A negative test for buprenorphine and/or2.A positive test for opioids, methadone, cocaine and/or heroin.
Keywords:
Buprenorphine-naloxone; Medications for treatment of opioid use disorder (MOUD); Opioid use disorder; Urine drug screen

Contacts :
0